[1]
Hu, Y. et al. 2022. Short Acting Beta Agonist Use Associated with Increased Mortality and Morbidity in Asthma Patients: A Systematic Review and Meta-Analysis. Journal of Pharmacy & Pharmaceutical Sciences. 25, (Jun. 2022), 193–200. DOI:https://doi.org/10.18433/jpps32738.